MichaelDominicPriviteraMD
Neurology • Cincinnati, OHEpilepsy
Professor of Neurology Director Epilepsy Center University of Cincinnati, Gardner Neuroscience Institute
Dr. Privitera is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3113 Bellevue Ave
Fl 3
Cincinnati, OH 45219Phone+1 513-652-6500Fax+1 513-475-8033
Summary
- Dr. Michael Privitera is a neurologist in Cincinnati, OH and is affiliated with multiple hospitals in the area, including University of Cincinnati Medical Center, Dayton Veterans Affairs Medical Center, and UC Health – West Chester Hospital. He received his medical degree from State University of New York Upstate Medical University and has been in practice 37 years. He specializes in epilepsy and is experienced in electroencephalography, epilepsy, antiepileptic drugs, and epilepsy and stress.
Education & Training
MedStar Health/Georgetown University HospitalResidency, Neurology, 1981 - 1984
California Pacific Medical CenterInternship, Internal Medicine, 1980 - 1981
SUNY Upstate Medical UniversityClass of 1980
Certifications & Licensure
OH State Medical License 1986 - 2026
TX State Medical License 1985 - 1988- American Board of Psychiatry and Neurology Neurology
- American Board of Psychiatry and Neurology Epilepsy
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Top MD Consumers Checkbook
Clinical Trials
- Stress Management Intervention for Living With Epilepsy (SMILE) Start of enrollment: 2012 Jan 01
- Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Chronic-Dose 4-Period Replicate Design Start of enrollment: 2013 Apr 01
- Equivalence Among Antiepileptic Drug Generic and Brand Products in People With Epilepsy: Single-Dose 6-Period Replicate Design (EQUIGEN Single-Dose Study) Start of enrollment: 2012 Dec 12
- Join now to see all
Publications & Presentations
PubMed
- 479 citationsFetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational studyKimford J. Meador, Gus A. Baker, Nancy Browning, Morris J. Cohen, Rebecca Bromley
The Lancet. Neurology. 2013-03-01 - 6 citationsA randomized controlled trial of self-management for people with epilepsy and a history of negative health events (SMART) targeting rural and underserved people with e...Gena R. Ghearing, Farren B.S. Briggs, Kristin A. Cassidy, Michael Privitera, Carol Blixen
Trials. 2021-11-20 - 188 citationsGenetic determinants of common epilepsies: a meta-analysis of genome-wide association studiesRichard Anney, Andreja Avbersek, David J. Balding, Larry Baum, Felicitas Becker
The Lancet. Neurology. 2014-07-30
Press Mentions
Sadly, Rappers and Seizures Usually Have One Thing in CommonDecember 9th, 2019
Add Seizures to the Risks Associated with E-cigarettes/Vaping FDA Urges Vigilance and Reporting in Alert to CliniciansNovember 22nd, 2019
Epilepsy Foundation Applauds the American Medical Association's Decision to Encourage Use of Telemedicine ProgramsJune 27th, 2019- Join now to see all
Grant Support
- Losigamone As Monotherapy In The Treatment Of ComplexNational Institute Of Neurological Disorders And Stroke1998–2000
- Losigamone As Monotherapy For Complex Partial SeizuresNational Institute Of Neurological Disorders And Stroke1997
- Remacemide Inpatient Seizure Evaluation TrialNational Institute Of Neurological Disorders And Stroke1992–1995
- ADD 94057 In Treatment Of Partial SeizuresNational Institute Of Neurological Disorders And Stroke1989–1991
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
